Showing results (391-400 of 445) with videos related to
Sort By:
Pageof 45
Headache|January 21, 2026
Patient perspectives on research gaps in cluster headacheFaraidoon Haghdoost, Dilara Bahceci, Candice Delcourt, et al.BMC Public Health|August 7, 2010
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular riskHueiming Liu, Anushka Patel, Alex Brown, et al.Hypertension (Dallas, Tex. : 1979)|June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAlexander Bennett, Clara K Chow, Michael Chou, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.Cephalalgia : an International Journal of Headache|June 23, 2023
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysisCheryl Carcel, Faraidoon Haghdoost, Joanne Shen, et al.The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.Heart (British Cardiac Society)|August 8, 2023
Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressureEmily R Atkins, Alexander Chye, Thomas Lung, et al.Pageof 45